The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Neuroendocrine tumor epidemiology: Contrasting Norway and North America
Open accessAbstract
BACKGROUND.: The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program has proven to be a significant resource in US neuroendocrine tumor (NET) epidemiology. Norway also holds a robust and detailed cancer registry: the Norwegian Registry of Cancer (NRC). METHODS.: SEER NET data were compared with corresponding NRC data in the time period 1993 to 2004 to determine whether there are differences in NET epidemiology between Norway and the United States. RESULTS.: The SEER and NRC reported 17,312 and 2030 NETs, respectively. The overall Caucasian SEER NET incidence was 4.44, compared with 3.24 in the NRC. In the SEER white subset, bronchopulmonary NETs were the most common (incidence = 1.42; 32% of all NETs), compared with small intestinal NETs in the NRC (0.81; 26%). A marked increase in SEER NET incidence (37%‐40%) was observed in the period 2000 to 2004, compared with 1993 to 1997; an even more pronounced increase (72%) was seen in the NRC. African Americans exhibited a remarkably high overall NET incidence of 6.50; furthermore, among African Americans, rectal NETs were most common (1.65; 27%). Small intestinal NET incidence was ∼30% higher in men compared with women in all populations. The highest 5‐year survival rates were for rectal NETs (74%‐88%) in both databases, whereas prostatic NETs had the worst outcome (0%‐23%). At diagnosis, NETs were localized in 27% to 46% of patients. CONCLUSIONS.: NET incidence in the US Caucasian population and in Norway is similar, but considerably higher (∼50%) among African Americans. NETs have been regarded as indolent tumors; however, the 5‐year survival is only ∼55%. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Self-citationLee, J. A. H. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03370120114036 · Cited by 2,243
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Self-citationIncome, Poverty, and Health Insurance Coverage In The United States: 2006: (668082007-001)
DeNavas-Walt, C., Proctor, B. D., & Smith, J. (2007) · PsycEXTRA Dataset · doi:10.1037/e668082007-001 · Cited by 1,636
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Carcinoid TumorsAn analysis of 2837 cases
Godwin, J. D. (1975) · Cancer · doi:10.1002/1097-0142(197508)36:2<560::aid-cncr2820360235>3.0.co;2-4 · Cited by 1,106
Gastric cancer epidemiology and risk factors
Kelley, J. R., & Duggan, J. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00534-6 · Cited by 750
Karzinoide Tumoren des Dunndarms
Oberndorfer, S. (1907) · Medical Entomology and Zoology · Cited by 578
Updated Population-Based Review of Carcinoid Tumors
Maggard, M. A., O??Connell, J. B., & Ko, C. Y. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000129342.67174.67 · Cited by 552
Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>3.0.co;2-r · Cited by 363
Cited by
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Lawrence, B., Gustafsson, B. I., Chan, A., Svejda, B., Kidd, M., & Modlin, I. M. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.12.005 · Cited by 861
Self-citationHallet, J., Law, C. H. L., Cukier, M., Saskin, R., Liu, N., & Singh, S. (2015) · Cancer · doi:10.1002/cncr.29099 · Cited by 852
Caplin, M. E., Baudin, E., Ferolla, P., Filosso, P., Garcia-Yuste, M., Lim, E., Oberg, K., Pelosi, G., Perren, A., Rossi, R. E., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv041 · Cited by 714
Falconi, M., Bartsch, D. K., Eriksson, B., Klöppel, G., Lopes, J. M., O'Connor, J. M., Salazar, R., Taal, B. G., Vullierme, M. P., & O'Toole, D. (2012) · Neuroendocrinology · doi:10.1159/000335587 · Cited by 526
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Pape, U.-F., Perren, A., Niederle, B., Gross, D., Gress, T., Costa, F., Arnold, R., Denecke, T., Plöckinger, U., Salazar, R., et al. (2012) · Neuroendocrinology · doi:10.1159/000335629 · Cited by 465
Niederle, M. B., Hackl, M., Kaserer, K., & Niederle, B. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-10-0152 · Cited by 444
Garcia-Carbonero, R., Capdevila, J., Crespo-Herrero, G., Díaz-Pérez, J. A., Martínez del Prado, M. P., Alonso Orduña, V., Sevilla-García, I., Villabona-Artero, C., Beguiristain-Gómez, A., Llanos-Muñoz, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq022 · Cited by 419
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?
Das, S., & Dasari, A. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01029-7 · Cited by 391
Pape, U.-F., Niederle, B., Costa, F., Gross, D., Kelestimur, F., Kianmanesh, R., Knigge, U., Öberg, K., Pavel, M., Perren, A., et al. (2016) · Neuroendocrinology · doi:10.1159/000443165 · Cited by 302
Xu, Z., Wang, L., Dai, S., Chen, M., Li, F., Sun, J., & Luo, F. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.24750 · Cited by 264
Carcinoid Tumors of the Gastrointestinal Tract: Trends in Incidence in England Since 1971
Ellis, L., Shale, M. J., & Coleman, M. P. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.341 · Cited by 261
Metadata
- Authors
- Hauso, O., Gustafsson, B. I., Kidd, M., Waldum, H. L., Drozdov, I., Chan, A. K. C., & Modlin, I. M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-11-03
- Volume
- 113
- Issue
- 10
- Pages
- 2655-2664
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2062011075
- Cited by
- 505
- References
- 29
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.